Results from a new study demonstrate that a structured exercise program can decrease fatigue in patients with advanced prostate cancer (aPC) undergoing androgen deprivation therapy (ADT). The study was presented at the 2025 ASCO Genitourinary Cancers Symposium (abstract 120).
Cancer-related fatigue, one of the most significant issues affecting quality of life, is reported by up to 75% of men with advanced prostate cancer on ADT.
In the new study, researchers prospectively enrolled men with
MARCH 31, 2025